Evaluation of a commercial enzyme immunoassay for HIV screening in urine
- 8 October 2004
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 23 (11), 831-835
- https://doi.org/10.1007/s10096-004-1221-6
Abstract
A cross-sectional study was conducted to evaluate the utility of a commercial enzyme immunoassay (EIA) as a screening test for detecting HIV-1 antibody in urine in a population at risk for HIV infection in Catalonia, Spain. Paired urine and serum samples were collected consecutively from 99 patients who attended two drug-dependency treatment centres and 151 patients who attended a sexually transmitted diseases (STD) clinic in Barcelona. Antibodies against HIV in urine samples were detected using the Calypte HIV-1 Urine EIA (Calypte Biomedical Corporation, Berkeley, CA, USA) and confirmed by urine-based Western blot (WB) analysis. Sera were analysed using Bioelisa HIV-1+2 EIA (Biokit Laboratories, Barcelona, Spain), and the results were verified using serum-based WB analysis. Results of both urine and serum testing were available for 246 of 250 participants. For 52 individuals the results of both urine and serum testing were positive and for five the results were discordant (2 with urine-negative/serum-positive results and 3 with urine-positive/serum-negative results). The respective sensitivity and specificity values obtained for the urine EIA were 100% and 96.2% for intravenous drug users (IDUs) and 80% and 99.3% for persons attending the STD clinic. According to the 1997 UNAIDS/WHO strategy I recommendations, these values are acceptable for surveillance purposes, particularly in populations with a high prevalence of HIV infection.Keywords
This publication has 26 references indexed in Scilit:
- Diagnostic Detection of Human Immunodeficiency Virus Type 1 Antibodies in Urine: a Brazilian StudyJournal of Clinical Microbiology, 2002
- Surveillance of HIV infection and related risk behaviour in European prisons. A multicentre pilot studyEuropean Journal of Public Health, 2001
- Comparative field evaluation of HIV rapid diagnostic assays using serum, urine, and oral mucosal transudate specimensClinical and Diagnostic Virology, 1997
- Urine samples as a possible alternative to serum for human immunodeficiency virus antibody screeningEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- Testing of saliva and serum for HIV in high-risk populationsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995
- Novel assay for the detection of immunoglobulin G antihuman immunodeficiency virus in untreated saliva and urineJournal of Medical Virology, 1993
- Risk behaviour, anti-HIV and anti-hepatitis B core prevalence in clinic and non-clinic samples of gay men in England; 1991–1992AIDS, 1993
- Use of urine for HIV-1 antibody screeningThe Lancet, 1990
- Absence of Infectious HIV-1 in the Urine of Seropositive Viremic SubjectsThe Journal of Infectious Diseases, 1989
- Antibodies to Human Immunodeficiency Virus Type 1 in the Urine Specimens of HIV-1-Seropositive IndividualsAIDS Research and Human Retroviruses, 1989